Skip to content

Understanding how Australian adults choose and follow very low calorie diet (VLCD) programs, their food and eating behaviours, and associated effects on self-perceived physical and mental health

Understanding how Australian adults choose and follow very low calorie diet (VLCD) programs, their food and eating behaviours, and associated effects on self-perceived physical and mental health

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12620001288910
Acronym
OPTIFAST RWE Study: Phase 2
Enrollment
600
Registered
2020-11-30
Start date
2020-12-01
Completion date
2021-10-31
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Sixty-six percent of the Australian adult population are overweight or obese. Recently, there has been growing interest in very-low-calorie diets (VLCDs) for weight loss, due to greater long-term weight loss success and being more tolerable than conventional weight loss programs. This nationwide cross-sectional survey aims to understand how Australian adults choose and follow very low calorie diet (VLCD) programs, their food and eating behaviours, and associated effects on self-perceived physical and mental health.

Interventions

Two groups of participants will be recruited: • Group 1: Participants who have used the OPTIFAST VLCD Program within the last 4 weeks, daily for 7 or more days in a row but do not meet the eligibility criteria for Group 2. Participants in this group will not answer all survey questions. • Group 2: Participants who have used the OPTIFAST VLCD Program more than a month, at least daily for 4 or more days/week and either continue to use or ceased use within the last 4 weeks. Participation involves

Two groups of participants will be recruited: • Group 1: Participants who have used the OPTIFAST VLCD Program within the last 4 weeks, daily for 7 or more days in a row but do not meet the eligibility criteria for Group 2. Participants in this group will not answer all survey questions. • Group 2: Participants who have used the OPTIFAST VLCD Program more than a month, at least daily for 4 or more days/week and either continue to use or ceased use within the last 4 weeks. Participation involves completion of a once-off online survey. The online survey involves multiple components including: - Demographic questionnaire - OPTIFAST VLCD program use questionnaire - Phyiscal activity questionnaire - Health-related quality of life questionnaire - Weight-related quality of life questionnaire - Eating behaviours questionnaire - Mental health questionnaire - Self-efficacy questionnaire They survey, including all questionnaires within the survey, will take 20 to 30 minutes in total to complete. Convenience and snowball sampling will be used to recruitment participants via an advertisement platform including: QR Codes on flyers placed in pharmacies, advertisement with electornic links to the survey on the OPTIFAST Website, social media (private posts and paid posts), and websites/electronic networks of health care professionals. At the completion of the questionnaire, if any responses indicate the participant may be using OPTIFAST unsafely, e.g. if they have a low BMI or are experiencing side-effects, they will recieve a message at teh end of the survey recommending they speak to their GP about their use of the OPTIFAST program. Participants will not be emailed a copy of their responses.

Sponsors

Nestlé Australia
Lead SponsorCommercial sector/Industry

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

- Aged 18-65yrs - Currently residing in Australia - Currently using or have used OPTIFAST VLCD at least once in the last 4 weeks (i.e. must have consumed an OPTIFAST VLCD product at least once daily for 7 consecutive days within the last 4 weeks then subsequently ended program use OR must have consumed an OPTIFAST VLCD product at least once a day for 5 days in a week for 4 weeks and either continue use or ceased use within the last 4 weeks).

Exclusion criteria

- Cannot understand written English - Pregnant women

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026